45th Annual Meeting—Scientific Sessions

R. Leung,C. Nwachukwu,A. Pervaiz,C. Walker,C. Landes,Nigel Broderick.,R. Hawkes,J. Somers,Rian Hoekstra,N. Kieviet,H. Nijs,R. Bilo,J. Zhong,M. Bitsori,E. Galanakis

DOI: https://doi.org/10.1007/s00247-008-0853-6

Pediatric Radiology

Abstract:

What problem does this paper attempt to address?

Evaluation of Therapy and Screening for Congenital Hypothyroidism in Neonates

CHEN Xiao-xiao,MAO Hua-qing,LIANG Li,CAO Li-pei,SHI Yu-hua,ZHOU Xue-lian,QU Yi-ping,WANG Xu,ZHAO Zheng-yan

DOI: https://doi.org/10.3969/j.issn.1003-515x.2006.02.005

2006-01-01

Testowy IndexCopernicus

Abstract:Objective To evaluate the efficacy of therapy and to analyze the data of follow-up by screening of congenital hypothyroidism(CH) in infants.Methods The levels of thyroid-stimulatin hormone(TSH) of dried blood sample on filter paper were measured by time-resolved fluoroimmunoassay.The values of serum TSH,triiodothyronine(T_3),thyroxine(T_4) were detected by chemilumine-(sence) in the recalled cases suspected CH.Patients confirmed with CH were treated by levothyroxine(L-T_4) initiated with 4-6 μg/((kg·d)) for 2-3 years.Growth and development,scintigraphy or ultrasonography of thyroid,intelligence,and bone age were investigated to(evaluate) the efficacy after stopping the treatment.Results A total of 557 193 neonates were screened for CH,339 cases of them were confirmed with CH(account for 1/1644).Two hundred and twenty-one cases were followed-up for more than 18 months during the(period) of treatment(lasting for 2 years 34 cases,3 years 34 cases,more than 3 years(75 cases)).One hundred cases were imaged on thyroid by scintigraphy and 150 cases by ultrasonography.The results revealed that 48 patients were of abnormal gland(32 cases with hypogenetic gland,8(cases) with ectopic gland,8 cases without any image of thyroid) and other 173 cases with normal gland.The average score of development quotient(DQ) was 106.5 and the cases of DQ larger than 85 was 98.6%.The bone age was normal in 75% cases and delay to normal in 25% cases.The high and weigh measured in all cases had reached normal criteria.Fourty-eight cases were confirmed with primary CH were received L-T_4 treatment forever,and that 86 out of 173 cases with temporary CH were continued no drugs.Among them,69 cases were confirmed temporary CH,9 cases with subclinical CH,and 8 cases with follow-up.Conclusion Neonatal screening together with efficacy treatment and regular follow-up is very important for the patient to attain normal body development and intelligence development.
Three Case Reports of Neonatal Hyperthyroidism

Xiu-Jing Wu,Li-Hua Chen,Ya-Ping Xu

DOI: https://doi.org/10.1097/ten.0b013e3181d4ab73

2010-01-01

The Endocrinologist

Abstract:To emphasize the causes, clinical features, diagnosis, management, and prognosis of hyperthyroidism in newborns, 3 cases of neonatal hyperthyroidism were analyzed. The cases were all low birth weight babies, and 2 of them were premature, the other was a term infant. Their mothers' histories were all positive for Graves' disease. In all cases, the infants exhibited tachycardia on admission. Case 1 presented mainly as splenohepatomegalia, case 2 presented mainly as heart failure and pneumonedema, whereas case 3 presented as hepatitis syndrome. The test of thyroid function and history of the mother confirmed the diagnosis of hyperthyroidism. Antithyroid drug therapy was administrated for all 3 cases, 2 with propylthiouracil and 1 with tapazole. In cases 1 and 2, thyroid function recovered after 4 to 5 weeks of treatment, and persisted for the following 3 months. Case 3 recovered after 3 months of therapy, which might be associated with a delay of diagnosis and severe symptoms. Neonatal hyperthyroidism is a rare disorder and usually associated with maternal Graves' disease. Although most neonatal hyperthyroidism is temporary, it may affect many organ systems and cause developmental delay in infants. Early diagnosis and prompt treatment consisting of antithyroid drugs in conjunction with iodine, beta-receptor blocking agents, and at times glucocorticoids and digoxin, are the key elements in management of this disease.
Clinical analysis about 2 789cases of congenital hypothyroidism

Ru-lai YANG,Fan TONG,Yan-hua XU,Zheng-yan ZHAO

DOI: https://doi.org/10.11852/zgetbjzz2017-25-11-04

2017-01-01

Abstract:Objective To study the cut-off value of screening congenital hypothyroidism (CH),and to analyze the different clinical features prognosis and influencing factors of permanent congenital hypothyroidism (PCH),and transient congenital hypothyroidism (TCH).Method A total of 2 789 cases of CH were enrolled in this research.Clinical data of newborn CH,diagnosed and followed-up in the neonatal screening center from August 1999 to April 2013,were collected retrospectively.The incidence,screening TSH values and complications of CH were assessed.According to whether the cases stop L-Thyroxine at 2 or 3 years old,participants were assigned into two groups:PCH group (n=682) and TCH group (n=621).The clinical features,prognosis,prognosis relevant factors were studied comparatively to PCH and TCH.And the clinical features of preterm CH and low-birth-weight newborn CH were also described.Result The neonatal screening incidence of CH was 1/1 886 in this study,the screening TSH level≥10 mU/L accounted for 97.5％ cases.The 682 cases of PCH and 621 cases of TCH were diagnosed.The radio of male/female,mean screening TSH value and inital dosage of PCH group were higher than those of TCH group (4.44:1 vs 1.14:1 and 96.4±82.3 mU/L vs 46.8±46.0 mU/L,respectively,P＜0.01).While the infant's age of serum FT4 values recovered,and the normal percentage of stature,bone age,DQ or IQ assessment of PCH group were lower than those of TCH group [(57.8±16.4) d vs (68.2±75.7) d,87.9％ vs 99.0％,92.9％ vs 96.7％ and 95.1％ vs 98.4％,respectively,P＜0.01].117 (PCH 22.2％) cases of preterm CH and 111 cases (PCH34.2 ％) of low-birth weight newborn CH were found.56 cases (8.2 ％) in PCH group reused L-Thyroxine during followed-up.The complicated incidence in 2 789 cases of CH was 2.1 ％.Conclusion The recommended cut off value in screening CH is ＞9 mU/L.The outcome of TCH was better than that of PCH.The high level of TSH level implies PCH.Preterm CH and low-birth-weight newborn CH need to be treatedstandard.CH cases need long-term following-up and systemic examination.
Screening for congenital hypothyroidism in neonates of Zhejiang Province during 1999-2004]

Xiao-xiao Chen,Ru-lai Yang,Yu-hua Shi,Li-pei Cao,Xue-lian Zhou,Hua-qing Mao,Zheng-yan Zhao

DOI: https://doi.org/10.3785/j.issn.1008-9292.2005.04.004

2005-01-01

Abstract:To analyze the data of screening for congenital hypothyroidism (CH) newborns in Zhejiang Province during 1999-2004.The dried blood samples were collected on filter paper. The levels of thyroid-stimulating hormone (TSH) were measured by time-resolved fluoroimmunoassay, and the serum levels of TSH, triiodothyronine (T(3)) and thyroxine (T(4)) were detected by chemiluminescence. Infants with CH confirmed by neonatal screening were treated with levothyroxine (L-T(4)) initiated with 4-6 g/kg x d(-1 )for 2-3 years. Growth, development and intelligence status, scintigraphy or ultrasonography of thyroid, and bone age were investigated to evaluate the efficacy of therapy during follow-ups.A total of 1112784 neonates were screened for CH during 1999-2004 with a coverage rate of 63.5%. Of the 6750 suspected CH cases, 6335 (93.8%) were recalled. 764 cases of CH were confirmed with an average incidence rate of 1 case CH per 1457 newborns (1/1457). 244 of 764 patients were followed-up for more than 1.5-2 years. All of them received thyroid by scintigraphy or ultrasonography. Among them 189 cases were found with normal gland, 35 with hypogenetic gland, 11 with ectopic gland, and the remaining 9 didn't show any image of thyroid. The average score of development quotient (DQ) was 106. 9. Among them, the DQ score was less than 85 in 2 cases, less than 90 in 9 cases, less than 100 in 28 cases, and in 68 cases the DQ was greater than 100. The bone age of 122 CH infants was evaluated with the X-ray radiography. In 90 cases of them,the bone age was normal, and 32 cases had progressed from development delay to normal. The height and weigh measured in all 106 cases had reached the related age criteria. The evaluation indicated that 55 cases were found with primary CH, 169 with temporary CH and 20 with subclinical CH.Neonatal screening for CH and regular treatment for CH patients are important for attaining normal body development and intelligence development of patients.
Treatment and Follow-Up of Children with Transient Congenital Hypothyroidism.

Yang Ru-lai,Zhu Zhi-wei,Zhou Xue-lian,Zhao Zheng-yan

DOI: https://doi.org/10.1631/jzus.2005.b1206

2005-01-01

Journal of Zhejiang University SCIENCE B

Abstract:Objective: To study the clinical therapy and prognosis in children with transient congenital hypothyroidism (CH). Methods: Fifty-seven children with CH diagnosed after neonatal screening were treated with low-dosage levothyroxine (L-T4). Follow-up evaluation included the determination of TT3, TT4 and TSH serum levels and the assessment of thyroid gland morphology, bone age, growth development and development quotients (DQ). A full check-up was performed at age 2, when the affected children first discontinued the L-T4 treatment for 1 month, and one year later. Development quotients were compared with a control group of 29 healthy peers. Results: The initial L-T4 dosage administered was 3.21:_5.81 µg/(kg·d) with an average of (16.25±3.87) µg/d. Mean duration of therapy was (28.09±9.56) months. No significant difference was found between study group and control group in the DQ test (average score (106.58±14.40) vs (102.4±8.6), P>0.05) and 96.49% of the CH children achieved a test score above 85. Bone age, 99mTc scans and ultrasonographic findings were all normal, and evaluation of physical development was normal too, as were the serum levels of TT3, TT4 and TSH after one year of follow-up. Conclusion: AL-T4 dosage of 3.21:_5.81 µg/(kg·d) was found sufficient for the treatment of transient CH. The treated children showed satisfactory overall mental and physical development at age 2. So it is possible for CH children to stop taking medicine if their laboratory findings and physical development are all normal after regular treatment and 2:_3 years of follow-up.
A1 AND C9 MARKER CHROMOSOMES IN CHILDREN WITH COMBINED MINOR AND MAJOR MALFORMATIONS

J. Kunze,G. Mau

DOI: https://doi.org/10.1016/S0140-6736(75)91167-8

IF: 202.731

1975-02-01

The Lancet

Abstract:
Congenital Hypothyroidism in Preterm Newborns - The Challenges of Diagnostics and Treatment: A Review

Martyna Klosinska,Agnieszka Kaczynska,Iwona Ben-Skowronek

DOI: https://doi.org/10.3389/fendo.2022.860862

2022-03-18

Abstract:Preterm newborns are forced to adapt to harsh extrauterine conditions and endure numerous adversities despite their incomplete growth and maturity. The inadequate thyroid hormones secretion as well as the impaired regulation of hypothalamus-pituitary-thyroid axis may lead to hypothyroxinemia. Two first weeks after birth are pivotal for brain neurons development, synaptogenesis and gliogenesis. The decreased level of thyroxine regardless of cause may lead to delayed mental development. Congenital hypothyroidism (CH) is a disorder highly prevalent in premature neonates and it originates from maternal factors, perinatal and labor complications, genetic abnormalities, thyroid malformations as well as side effects of medications and therapeutic actions. Because of that, the prevention is not fully attainable. CH manifests clinically in a few distinctive forms: primary, permanent or transient, and secondary. Their etiologies and implications bear little resemblance. Therefore, the exact diagnosis and differentiation between the subtypes of CH are crucial in order to plan an effective treatment. Hypothyroxinemia of prematurity indicates dynamic changes in thyroid hormone levels dependent on neonatal postmenstrual age, which directly affects patient's maintenance and wellbeing. The basis of a successful treatment relies on an early and accurate diagnosis. Neonatal screening is a recommended method of detecting CH in preterm newborns. The preferred approach involves testing serum TSH and fT4 concentrations and assessing their levels according to the cut-off values. The possible benefits also include the evaluation of CH subtype. Nevertheless, the reference range of thyroid hormones varies all around the world and impedes the introduction of universal testing recommendations. Unification of the methodology in neonatal screening would be advantageous for prevention and management of CH. Current guidelines recommend levothyroxine treatment of CH in preterm infants only when the diagnose is confirmed. Moreover, they underline the importance of the re-evaluation among preterm born infants due to the frequency of transient forms of hypothyroidism. However, results from multiple clinical trials are mixed and depend on the newborn's gestational age at birth. Some benefits of treatment are seen especially in the preterm infants born <29 weeks' gestation. The discrepancies among trials and guidelines create an urgent need to conduct more large sample size studies that could provide further analyses and consensus. This review summarizes the current state of knowledge on congenital hypothyroidism in preterm infants. We discuss screening and treatment options and demonstrate present challenges and controversies.
[Influence of Congenital Hypothyroidism on Left Ventricular Function of Neonates].

Shan-shan Mao,Zheng-yan Zhao,Guo-ping Jiang

DOI: https://doi.org/10.3760/j.issn:0578-1310.2004.07.007

2004-01-01

Abstract:OBJECTIVE:To evaluate left ventricular function in neonates with congenital hypothyroidism (CH) and its correlation with thyroid hormones serum levels.METHODS:M-mode echocardiography [left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS)], pulse wave Doppler [the peak early diastolic mitral inflow velocity (Em), the peak late diastolic mitral inflow velocity (Am)], quantitative tissue velocity imaging (QTVI) [the systolic peak mitral annular velocity (sm), the early diastolic peak mitral annular velocity (em), the late diastolic peak mitral annular velocity (am)] and tissue tracking imaging (TTI) [the systolic mitral annular displacement (MAD)] were evaluated in 35 neonates with congenital hypothyroidism aged 15-28 days and 30 normal neonates in this study. Correlation analysis was also made between left ventricular function and serum TT3, TT4 and TSH levels.RESULTS:Left systolic function parameters (LVEF, LVFS, sm and MAD) were 0.62 +/- 0.08, (28.21 +/- 5.31)%, (2.58 +/- 0.59) cm/s and (0.27 +/- 0.07) cm, respectively, in CH group, and 0.67 +/- 0.06, (31.16 +/- 4.13)%, (3.24 +/- 0.52) cm/s and (0.41 +/- 0.08) cm in control group (P < 0.05, P < 0.01). Left diastolic function parameters (Am, Em/Am, em/am, Em and em) were (0.59 +/- 0.10) m/s, 0.98 +/- 0.18, 0.82 +/- 0.40, (0.57 +/- 0.11) m/s and (2.83 +/- 1.48) cm/s, respectively, in CH group, and (0.65 +/- 0.10) m/s, 1.14 +/- 0.20, 1.25 +/- 0.33, (0.73 +/- 0.11) m/s and (4.46 +/- 1.29) cm/s in control group (P < 0.05, P < 0.01). MAD, sm, Em and em in CH group were greatly lower than that in control group (P < 0.001). Left systolic function (LVEF, sm, MAD) and diastolic function (Em, Am, em, em/am) were positively correlated with TT3, TT4 serum levels (P < 0.05, P < 0.01), and negatively with TT4 serum levels (P < 0.05, P < 0.01). MAD, Em and em were highly correlated with TT4, TSH serum levels (r = 0.700, r = 0.564, r = 0.593, r = 0.564, P < 0.001; r = -0.674, r = -0.521, r = -0.578, r = -0.632, P < 0.001).CONCLUSIONS:Neonates with CH have lower left systolic and diastolic function. Left ventricular function was affected by thyroid hormones. QTVI and TTI are more sensitive parameters in evaluating left ventricular function of neonates with congenital hypothyroidism than conventional echocardiography.
Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening

Xiao-Xiao Chen,Yu-Feng Qin,Xue-Lian Zhou,Ru-Lai Yang,Yu-Hua Shi,Hua-Qing Mao,Yi-Ping Qu,Xu Wang,Zheng-Yan Zhao

DOI: https://doi.org/10.1007/s12519-011-0314-4

2011-01-01

Abstract:Background This study was undertaken to explore the clinical outcome and prognosis of subclinical hypothyroidism detected by newborn screening. Methods Newborn screening was conducted at 1156 health care institutions in Zhejiang Province from October 1999 to September 2006. Included were (1) infants who had thyroid-stimulating hormone (TSH) ≥20 mU/L, and normal or lower normal levels of triiodothyronine (T 3 ) and thyroxine (T 4 ) and (2) infants with TSH between 5.6 mU/L and 20 mU/L at a confirmatory examination and follow-up showing TSH levels ≥20 mU/L or delayed reduction in T 4 levels. These infants were considered as having subclinical hypothyroidism and levothyroxine (L-T 4 ) at an initial dose of 3–5 μg/kg per day was administered. The levels of TSH and T 4 , developmental quotient (DQ), and index of growth were evaluated. Results A total of 204 infants met our criteria for subclinical hypothyroidism, with an incidence of 1/8809. After 2–4 weeks of standard therapy, serum TSH level dropped to normal and T 4 reached a higher normal level in all the 204 infants. Evaluations of 60 patients after 2 years of therapy showed that their average DQ was 101±14.61, and body weight and height were within the normal ranges. Bone age test for 54 patients revealed normal development in 44, slightly retarded development in 7, and advanced development in 3. Conclusions Newborns with high TSH levels should be given particular attention to ensure early diagnosis. A L-T 4 dose of 3–5 μg/kg per day was effective in the initial treatment of subclinical hypothyroidism.
Congenital Hypothyroidism

Jacqueline Brady,Ashton Cannupp,Jordan Myers,Amy J Jnah

DOI: https://doi.org/10.1891/11-T-699

2021-11-01

Abstract:Congenital hypothyroidism (CH) is a disorder of thyroid hormone deficiency which develops secondary to incomplete thyroid development or inadequate thyroid hormone production. State-mandated newborn screening throughout the United States has increased the detection rate of CH, allowing for early intervention. Although the overall mortality rate of CH is low, delayed or omitted treatment can lead to devastating neurocognitive outcomes. As such, CH is regarded as the leading cause of preventable intellectual disability in children. Early identification, facilitated by astute neonatal nursing and medical care, is contingent upon an active working knowledge of the disease process and awareness of the limitations of the newborn screen.
Monozygotic Twin Boys Concordant for Congenital Hypothyroidism: Two Cases

H. Q. Mao,L. L. Yang,X. W. Huang,R. L. Yang,Z. Y. Zhao

2010-01-01

Hong kong journal of paediatrics

Abstract:Twins or multi-pregnancy is reported to have much higher risks for congenital hypothyroidism (CH), and most twins are discordant for CH. Monozycotic twins concordant for CH are rare. We describe two monozygotic twin-pairs concordant for CH. Filter paper screening was performed and a blood spot thyroid-stimulating hormone (TSH) value higher than 9 mU/L led to recall for whole blood evaluation One of each twin pairs was normal at initial neonatal screening, while delayed TSH elevation and low T4 level were found in the diagnosis testing 2-3 weeks later. The L-thyroxine (L-T4) replacement therapy was initiated when the diagnosis was made. The initial dosage of L-T4 for the twins was 8 mu g/d/kg. After 16 months of follow-up, thyroid function and development were all normal for the twin pairs
The Natural Course of Newborns with Transient Congenital Hypothyroidism

Tal Almagor,Shlomo Almashanu,Ghadir Elias Assad,Osnat Admoni,Hanna Ludar,Shira London,Shoshana Rath,Alina German,Naama Schwartz,Yardena Tenenbauim Rakover

DOI: https://doi.org/10.1530/ec-24-0316

2024-10-18

Endocrine Connections

Abstract:Objectives: The incidence of congenital hypothyroidism (CH) has increased worldwide over the last decades mainly due to the lowering of screening thresholds, resulting in an increased identification of newborns with transient CH. Several studies reported the prevalence and the predictive parameters of transient CH but reports on the long-term outcome are rare. This study aimed to assess the long-term course of neonates with transient CH. Design: Neonates diagnosed with transient and permanent CH between the years 1998 to 2018 at the Pediatric Endocrine Institute of Ha'Emek Medical Center were enrolled in the study. Data were retrieved retrospectively from medical files. Results: Included in the study were 76 newborns (45M,59%) with transient CH and 53 (25M,47%) with permanent CH. The major cause of transient CH was prematurity (29%) and subclinical hypothyroidism (30%). During retrospective follow-ups of up to 23 years, reinitiation of LT4 therapy was not required apart from four patients with underlying syndromic etiologies. Neurodevelopmental impairment occurred in 16% of children with transient CH compared with 29.4% in the permanent CH group. Conclusions: Transient CH is frequent among preterm infants but is limited to infancy. SCH frequently presents as overt hypothyroidism at birth but in most cases the requirement for LT4 supplemental therapy is limited to the first years of life, suggesting that long-term follow-up of thyroid function tests may be unnecessary for non-syndromic children. The high rate of neurodevelopmental impairment in newborns with transient CH emphasizes the need for neurodevelopmental monitoring in these patients.

endocrinology & metabolism
Congenital Hypothyroidism: Screening and Management

Susan R Rose,Ari J Wassner,Kupper A Wintergerst,Nana-Hawa Yayah-Jones,Robert J Hopkin,Janet Chuang,Jessica R Smith,Katherine Abell,Stephen H LaFranchi,SECTION ON ENDOCRINOLOGY EXECUTIVE COMMITTEE,COUNCIL ON GENETICS EXECUTIVE COMMITTEE,Kathleen E Bethin,Jill L Brodsky,David H Jelley,Bess A Marshall,Lucy D Mastrandrea,Jane L Lynch,Laura Laskosz,Leah W Burke,Timothy A Geleske,Ingrid A Holm,Wendy J Introne,Kelly Jones,Michael J Lyons,Danielle C Monteil,Amanda B Pritchard,Pamela Lyn Smith Trapane,Samantha A Vergano,Kathryn Weaver,Aimee A Alexander,Christopher Cunniff,Mary E Null,Melissa A Parisi,Steven J Ralson,Joan Scott,Paul Spire

DOI: https://doi.org/10.1542/peds.2022-060420

2023-01-01

PEDIATRICS

Abstract:Untreated congenital hypothyroidism (CH) leads to intellectual disabilities. Prompt diagnosis by newborn screening (NBS) leading to early and adequate treatment results in grossly normal neurocognitive outcomes in adulthood. However, NBS for hypothyroidism is not yet established in all countries globally. Seventy percent of neonates worldwide do not undergo NBS.The initial treatment of CH is levothyroxine, 10 to 15 mcg/kg daily. The goals of treatment are to maintain consistent euthyroidism with normal thyroid-stimulating hormone and free thyroxine in the upper half of the age-specific reference range during the first 3 years of life. Controversy remains regarding detection of thyroid dysfunction and optimal management of special populations, including preterm or low-birth weight infants and infants with transient or mild CH, trisomy 21, or central hypothyroidism.Newborn screening alone is not sufficient to prevent adverse outcomes from CH in a pediatric population. In addition to NBS, the management of CH requires timely confirmation of the diagnosis, accurate interpretation of thyroid function testing, effective treatment, and consistent follow-up. Physicians need to consider hypothyroidism in the face of clinical symptoms, even if NBS thyroid test results are normal. When clinical symptoms and signs of hypothyroidism are present (such as large posterior fontanelle, large tongue, umbilical hernia, prolonged jaundice, constipation, lethargy, and/or hypothermia), measurement of serum thyroid-stimulating hormone and free thyroxine is indicated, regardless of NBS results.
[Neonatal screening for congenital hypothyroidism]

Juliane Léger

DOI: https://doi.org/10.1051/medsci/2021058

Abstract:Congenital hypothyroidism (CH) is the leading cause of preventable mental retardation. It is mainly due to thyroid dysgenesis or dyshormonogenesis with normally located gland, and detected at birth in developed countries by systematic neonatal screening. The early treatment of patients with CH has successfully improved the prognosis and management of this disease. An increase in the incidence of congenital hypothyroidism with a normally located gland has been reported worldwide over the last three decades. The etiology of CH with a normally located gland remains elusive and about half of them demonstrate spontaneous resolution of CH within a few months (transient CH). They highlight the need to reevaluate thyroid function during follow-up.
Fat versus lean: the quest for beautiful buttocks.

A. Higgins

DOI: https://doi.org/10.1016/J.TVJL.2004.01.020

IF: 2.75

2004-05-01

The Veterinary Journal

Abstract:
Different Forms of Hypothyroidism in Infants with Maternal Graves' Disease: A Case Series

Alexis Anand Dass Lordudass,Jeanne Sze Lyn Wong,Nalini Selveindran,Janet Yeow Hua Hong

DOI: https://doi.org/10.15605/jafes.039.01.06

Abstract:Infants of mothers with Graves' disease (GD) may develop central hypothyroidism (CH) due to exposure of the foetal hypothalamic-pituitary-thyroid axis to higher-than-normal thyroid hormone concentrations, primary hypothyroidism (PH) due to transplacental passage of maternal thyroid stimulating hormone receptor antibody (TRAb), antithyroid drugs (ATD) or thyroid dysgenesis secondary to maternal uncontrolled hyperthyroidism. We describe two infants with PH and four infants with CH born to mothers with poorly controlled Graves' disease. All infants required levothyroxine and had normal developmental milestones. While national guideline consensus for high thyroid stimulating hormone (TSH) on neonatal screening is well-established, thyroid function tests (TFTs) should be serially monitored in infants with low TSH on screening, as not all mothers with Graves' disease are diagnosed antenatally.
Insights into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis

Alina German,Shlomo Almashanu,Liat de Vries,Merav Gil Margolis,Rana Halloun,Alon Haim,Ori Eyal,Floris Levy-Khademi,Dikla Pivko-Levy,Judith Nir,Orit Pinhas-Hamiel,Yardena Tenenbaum-Rakover

DOI: https://doi.org/10.1210/clinem/dgae485

2024-07-15

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Context Central congenital hypothyroidism (CCH) is a thyroid hormone deficiency at birth caused by inadequate pituitary stimulation of the thyroid gland. Although primary CH has been studied extensively, studies on CCH are sparse. Objectives To assess the prevalence of CCH in Israel and describe its clinical features, neonatal screening results, and outcomes. Design Multicenter cross-sectional retrospective chart review. Setting Nine pediatric endocrine units throughout Israel. Patients Patients diagnosed with CCH in 1987–2021 were categorized into early (within 14 days of life) and late (after 14 days) diagnosis groups. Newborn screening (NBS) results were retrospectively retrieved from the national NBS program dataset. Results CCH prevalence in Israel was about 1:42,800 live births. Subjects were 94 patients (54 males), of these, 84% had multiple pituitary hormone deficiencies and 16% had isolated CCH. The median age at diagnosis was 50 days (range, 1–8760), with 66% having moderate to severe hypothyroidism. NBS detected only three infants. Early diagnosis occurred in 34% due to hypopituitarism, while 66% were diagnosed later due to growth and developmental delays. Neurodevelopmental sequelae included mental retardation (12%), learning difficulties (18%), delayed speech (27%), and motor clumsiness (19%), with no significant differences in outcomes between early and late diagnosis. Conclusions Despite high rates of neurodevelopmental sequelae, no differences were found between early and late diagnosis groups. Further research is needed to assess the impact of delayed diagnosis on neurological outcomes in newborns with CCH. Improved strategies for detecting CHH in newborns are also necessary.

endocrinology & metabolism
MON-082 The Neonatal Screen That Cried Wolff

Fabiola D’Ambrosio,Laika M Nur,Stelios Mantis,Carla Z Minutti

DOI: https://doi.org/10.1210/jendso/bvaa046.298

2020-04-01

Journal of the Endocrine Society

Abstract:Abstract Introduction: Hypothyroidism is one of the major causes of preventable mental retardation. Neonatal screening aids in the prompt diagnosis of newborns with congenital hypothyroidism. There are other clinical conditions that can alter thyroid function during the newborn period, including exposure of high iodine concentrations. Case Presentation: One day old female born at 37 3/7 weeks of gestational age by C-section with imperforated anus and congenital heart disease was transferred to our children’s hospital within the first day of life for a hybrid cardiac procedure of bilateral pulmonary artery banding and PDA stenting. She had an Illinois Neonatal screen done at 36 hours of life that was normal. Her cardiac surgery was performed at 10 days of life, where she was exposed to iodine products transdermally. At 14 days of age, she had a repeat Illinois Neonatal screen that was positive for congenital hypothyroidism with a TSH of 78 mIu/mL (normal < 20 mIu/mL) and reflex total T4 of 5.4ug/dL (normal is > 8ug/dL). No family history of thyroid disease; mother was healthy during pregnancy and was not on medications that could affect baby’s thyroid function. Subsequent serum laboratory testing confirmed a TSH of 74.3mIu/mL and Free T4 of 0.6ng/dL. Patient was diagnosed with Wolff-Chaikoff effect, which is the phenomenon of transient hypothyroidism caused by exposure to high doses of iodine (iodine containing contrast agents or topical antiseptics). Pediatric Endocrinology was consulted at 2 weeks of life and she was started on 25mcg of levothyroxine PO daily. Levothyroxine dose decreased at 16 month of age to 12.5mcg due to stable thyroid function tests. The patient was last seen at 30 months of age by Pediatric Endocrinology. She is still on the low dose of levothyroxine and her thyroid labs have been within normal limits for an infant. She will likely not require lifelong thyroid supplementation. Conclusion: Risk of hypothyroidism among neonates must be considered seriously after large iodine exposure and monitoring for transient hypothyroidism should be performed. It is thus recommended that attempts should be made to reduce the amount of iodine used during procedures and to carefully monitor thyroid function in all neonates exposed to an excess of iodine. Reference: Markou, K., et al. “Iodine-Induced Hypothyroidism.” Thyroid, vol. 11, no. 5, 2001, pp. 501–510., doi:10.1089/105072501300176462. Linder N, Sela B, German B, et al. Iodine and hypothyroidism in neonates with congenital heart disease. Archives of Disease in Childhood - Fetal and Neonatal Edition 1997;77:F239-F240. Kovacikova, Lubica, et al. “Thyroid Function and Ioduria in Infants after Cardiac Surgery: Comparison of Patients with Primary and Delayed Sternal Closure.” Pediatric Critical Care Medicine, vol. 6, no. 2, 1 Mar. 2005, pp. 154–159., doi:10.1097/01.pcc.0000154960.59452.06.

English Else
Fetal and Neonatal Thyroid Dysfunction

Juliane Léger,Clemence Delcour,Jean-Claude Carel

DOI: https://doi.org/10.1210/clinem/dgab747

2022-02-17

Abstract:Fetal and neonatal dysfunctions include rare serious disorders involving abnormal thyroid function during the second half of gestation, which may persist throughout life, as for most congenital thyroid disorders, or be transient, resolving in the first few weeks of life, as in autoimmune hyperthyroidism or hypothyroidism and some cases of congenital hypothyroidism (CH) with the thyroid gland in situ. Primary CH is diagnosed by neonatal screening, which has been implemented for 40 years in developed countries and should be introduced worldwide, as early treatment prevents irreversible neurodevelopmental delay. Central CH is a rarer entity occurring mostly in association with multiple pituitary hormone deficiencies. Other rare disorders impair the action of thyroid hormones. Neonatal Graves' disease (GD) results from the passage of thyrotropin receptor antibodies (TRAbs) across the placenta, from mother to fetus. It may affect the fetuses and neonates of mothers with a history of current or past GD, but hyperthyroidism develops only in those with high levels of stimulatory TRAb activity. The presence of antibodies predominantly blocking thyroid-stimulating hormone receptors may result in transient hypothyroidism, possibly followed by neonatal hyperthyroidism, depending on the balance between the antibodies present. Antithyroid drugs taken by the mother cross the placenta, treating potential fetal hyperthyroidism, but they may also cause transient fetal and neonatal hypothyroidism. Early diagnosis and treatment are key to optimizing the child's prognosis. This review focuses on the diagnosis and management of these patients during the fetal and neonatal periods. It includes the description of a case of fetal and neonatal autoimmune hyperthyroidism.
Long-term Consequences of the Early Treatment of Children with Congenital Hypothyroidism Detected by Neonatal Screening in Nanjing, China: a 12-Year Follow-up Study

Qiang Sun,Y.-L. Chen,Zhangbin Yu,Shihui Han,Xiaoyan Dong,Yan Qiu,Lijuan Sha,Xirong Guo

DOI: https://doi.org/10.1093/tropej/fmr010

2011-01-01

Journal of Tropical Pediatrics

Abstract:This study was performed to investigate the prevalence of congenital hypothyroidism (CH) in neonates in Nanjing, China and the long-term consequences of early treatment. A total of 442 454 neonates were screened for CH and 183 neonates were confirmed, with a prevalence of 1 in 2418. Of these, 163 neonates completed the follow-up process and 163 healthy children were recruited as the control group. The height, weight and body mass index (BMI) of the children with CH from 0.5 to 6 years were not significantly different from the control group (p > 0.05). The children with CH had a significantly increased risk for being overweight or obese between 0.5 and 6 years (p < 0.05). The children with CH showed a significantly lower developmental quotient (DQ) than the control group in all four areas of the Gesell test (p < 0.05). The results suggest that children with CH that has been identified by newborn screening and early treatment have normal growth and neuromotor development.

45th Annual Meeting—Scientific Sessions

Evaluation of Therapy and Screening for Congenital Hypothyroidism in Neonates

Three Case Reports of Neonatal Hyperthyroidism

Clinical analysis about 2 789cases of congenital hypothyroidism

Screening for congenital hypothyroidism in neonates of Zhejiang Province during 1999-2004]

Treatment and Follow-Up of Children with Transient Congenital Hypothyroidism.

A1 AND C9 MARKER CHROMOSOMES IN CHILDREN WITH COMBINED MINOR AND MAJOR MALFORMATIONS

Congenital Hypothyroidism in Preterm Newborns - The Challenges of Diagnostics and Treatment: A Review

[Influence of Congenital Hypothyroidism on Left Ventricular Function of Neonates].

Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening

Congenital Hypothyroidism

Monozygotic Twin Boys Concordant for Congenital Hypothyroidism: Two Cases

The Natural Course of Newborns with Transient Congenital Hypothyroidism

Congenital Hypothyroidism: Screening and Management

[Neonatal screening for congenital hypothyroidism]

Fat versus lean: the quest for beautiful buttocks.

Different Forms of Hypothyroidism in Infants with Maternal Graves' Disease: A Case Series

Insights into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis

MON-082 The Neonatal Screen That Cried Wolff

Fetal and Neonatal Thyroid Dysfunction

Long-term Consequences of the Early Treatment of Children with Congenital Hypothyroidism Detected by Neonatal Screening in Nanjing, China: a 12-Year Follow-up Study